Janus Henderson Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.31M Buy
73,488
+1,537
+2% +$200K ﹤0.01% 849
2025
Q4
$8.75M Buy
71,951
+52,530
+270% +$6.59M ﹤0.01% 775
2025
Q3
$2.18M Buy
19,421
+1,326
+7% +$155K ﹤0.01% 1297
2025
Q2
$2.42M Sell
18,095
-38,384
-68% -$4.21M ﹤0.01% 1198
2025
Q1
$3.87M Buy
56,479
+41,016
+265% +$2.82M ﹤0.01% 976
2024
Q4
$965K Hold
15,463
﹤0.01% 1708
2024
Q3
$2.43M Buy
15,463
+1,428
+10% +$220K ﹤0.01% 1214
2024
Q2
$2.11M Sell
14,035
-163
-1% -$19.6K ﹤0.01% 1237
2024
Q1
$1.05M Buy
14,198
+1
+0% +$82 ﹤0.01% 1615
2023
Q4
$1.12M Sell
14,197
-25
-0.2% -$1.51K ﹤0.01% 1565
2023
Q3
$778K Buy
14,222
+2
+0% +$144 ﹤0.01% 1692
2023
Q2
$1.19M Sell
14,220
-14
-0.1% -$1.07K ﹤0.01% 1517
2023
Q1
$1.08M Buy
14,234
+9,217
+184% +$637K ﹤0.01% 1587
2022
Q4
$310K Buy
5,017
+1
+0% +$53 ﹤0.01% 1959
2022
Q3
$209K Buy
+5,016
New +$218K ﹤0.01% 2389
2019
Q3
Sell
-519,440
Closed -$15.1M 1435
2019
Q2
$15.1M Buy
+519,440
New +$14.2M 0.01% 861

Other funds holding TMDX

Janus Henderson Group's TMDX Position: Q1 2026 in Review

Janus Henderson Group increased its Transmedics (TMDX) stake by 2.1% in Q1 2026, buying an estimated $200K and bringing the position to 73,488 shares worth $7.31M. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Janus Henderson Group first reported a position in TMDX in Q2 2019 and has held it in 16 quarters since. The position peaked at $15.1M in Q2 2019. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Janus Henderson Group held 73,488 shares of Transmedics worth $7.31M as of Q1 2026.
  • Janus Henderson Group bought 1,537 Transmedics shares in Q1 2026, an estimated $200K.
  • Transmedics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #849 holding.
  • Janus Henderson Group first reported a position in Transmedics in Q2 2019 and has held it in 16 quarters since.
  • Janus Henderson Group's Transmedics position peaked at $15.1M in Q2 2019.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.